메뉴 건너뛰기




Volumn 53, Issue 2, 2004, Pages 125-134

Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma

Author keywords

Clinical responses; Dendritic cells; Immune responses; Melanoma; Melanoma peptides

Indexed keywords

AUTOANTIGEN; CYTOKINE; DACARBAZINE; GAMMA INTERFERON; GLYCOPROTEIN GP 100; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; MELAN A; MELANOMA ANTIGEN; MELANOMA ANTIGEN 3.A2; MELANOMA VACCINE; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

EID: 0742269426     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0429-0     Document Type: Article
Times cited : (110)

References (58)
  • 1
    • 0030925810 scopus 로고    scopus 로고
    • The treatment of metastatic melanoma with chemotherapy: Biologics
    • Atkins MB (1997) The treatment of metastatic melanoma with chemotherapy: biologics. Curr Opin Oncol 9:205
    • (1997) Curr Opin Oncol , vol.9 , pp. 205
    • Atkins, M.B.1
  • 2
    • 0039821585 scopus 로고    scopus 로고
    • Phase III trial of melacine melanoma theraccine versus combination chemotherapy in the treatment of stage IV melanoma
    • Von Eschen KB, Mitchell MS (1997) Phase III trial of melacine melanoma theraccine versus combination chemotherapy in the treatment of stage IV melanoma. Melanoma Res 7:S51
    • (1997) Melanoma Res , vol.7
    • Von Eschen, K.B.1    Mitchell, M.S.2
  • 3
    • 0036138677 scopus 로고    scopus 로고
    • Advances in the non-surgical treatment of melanoma
    • Hersey P (2002) Advances in the non-surgical treatment of melanoma. Expert Opin Investig Drugs 11:75
    • (2002) Expert Opin Investig Drugs , vol.11 , pp. 75
    • Hersey, P.1
  • 4
    • 0030016719 scopus 로고    scopus 로고
    • Dendritic cells and immune-based therapies
    • Steinman RM (1996) Dendritic cells and immune-based therapies. Exp Hematol 24:859
    • (1996) Exp Hematol , vol.24 , pp. 859
    • Steinman, R.M.1
  • 7
  • 9
    • 0030048724 scopus 로고    scopus 로고
    • Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity
    • Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr (1996) Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 183:283
    • (1996) J Exp Med , vol.183 , pp. 283
    • Celluzzi, C.M.1    Mayordomo, J.I.2    Storkus, W.J.3    Lotze, M.T.4    Falo Jr., L.D.5
  • 10
    • 0030058647 scopus 로고    scopus 로고
    • Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
    • Zitvogel L, Mayordomo JI, Tjandrawan T, Deleo AB, Clarke MR, Lotze MT, Storkus WJ (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183:87
    • (1996) J Exp Med , vol.183 , pp. 87
    • Zitvogel, L.1    Mayordomo, J.I.2    Tjandrawan, T.3    Deleo, A.B.4    Clarke, M.R.5    Lotze, M.T.6    Storkus, W.J.7
  • 13
    • 0034181264 scopus 로고    scopus 로고
    • Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells
    • Mackensen A, Herbst B, Chen JL, Kohler G, Noppen C, Herr W, Spagnoli GC, Cerundolo V, Lindemann A (2000) Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer 86:385
    • (2000) Int J Cancer , vol.86 , pp. 385
    • Mackensen, A.1    Herbst, B.2    Chen, J.L.3    Kohler, G.4    Noppen, C.5    Herr, W.6    Spagnoli, G.C.7    Cerundolo, V.8    Lindemann, A.9
  • 14
    • 0033934224 scopus 로고    scopus 로고
    • Phase I study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100
    • Panelli MC, Wunderlich J, Jeffries J, Wang E, Mixon A, Rosenberg SA, Marincola FM (2000) Phase I study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100. J Immunother 23:487
    • (2000) J Immunother , vol.23 , pp. 487
    • Panelli, M.C.1    Wunderlich, J.2    Jeffries, J.3    Wang, E.4    Mixon, A.5    Rosenberg, S.A.6    Marincola, F.M.7
  • 18
    • 0030946403 scopus 로고    scopus 로고
    • Melanoma vaccines: Prospects for the treatment of melanoma
    • Hersey P (1997) Melanoma vaccines: prospects for the treatment of melanoma. Expert Opin Investig Drugs 6:267
    • (1997) Expert Opin Investig Drugs , vol.6 , pp. 267
    • Hersey, P.1
  • 20
    • 0030587077 scopus 로고    scopus 로고
    • Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues
    • Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y (1996) Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J Immunol 157:2539
    • (1996) J Immunol , vol.157 , pp. 2539
    • Parkhurst, M.R.1    Salgaller, M.L.2    Southwood, S.3    Robbins, P.F.4    Sette, A.5    Rosenberg, S.A.6    Kawakami, Y.7
  • 22
    • 0041485051 scopus 로고    scopus 로고
    • Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo
    • Jaeger E, Ringhoffer M, Dienes HP, Arand M, Karbach J, Jager D (1996) Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer 67:54
    • (1996) Int J Cancer , vol.67 , pp. 54
    • Jaeger, E.1    Ringhoffer, M.2    Dienes, H.P.3    Arand, M.4    Karbach, J.5    Jager, D.6
  • 23
    • 0035889605 scopus 로고    scopus 로고
    • Primary melanoma tumour regression associated with an immune response to the tumour-assocated antigen melan-A/MART-1
    • Saleh FH, Crotty KA, Hersey P, Menzies SW (2001) Primary melanoma tumour regression associated with an immune response to the tumour-assocated antigen melan-A/MART-1. Int J Cancer 94:551
    • (2001) Int J Cancer , vol.94 , pp. 551
    • Saleh, F.H.1    Crotty, K.A.2    Hersey, P.3    Menzies, S.W.4
  • 25
    • 0029837404 scopus 로고    scopus 로고
    • Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides
    • Salgaller ML, Marincola FM, Cormier JN, Rosenberg SA (1996) Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides. Cancer Res 56:4749
    • (1996) Cancer Res , vol.56 , pp. 4749
    • Salgaller, M.L.1    Marincola, F.M.2    Cormier, J.N.3    Rosenberg, S.A.4
  • 26
    • 0036839330 scopus 로고    scopus 로고
    • CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation
    • Cao X, Sugita M, Van Der Wel N, Lai J, Rogers RA, Peters PJ, Brenner MB (2002) CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J Immunol 169:4770
    • (2002) J Immunol , vol.169 , pp. 4770
    • Cao, X.1    Sugita, M.2    Van Der Wel, N.3    Lai, J.4    Rogers, R.A.5    Peters, P.J.6    Brenner, M.B.7
  • 27
    • 0030802336 scopus 로고    scopus 로고
    • CD11c integrin gene promoter activity during myeloid differentation
    • Corbi AL, Lopez-Rodriguez C (1997) CD11c integrin gene promoter activity during myeloid differentation. Leuk Lymphoma 25:415
    • (1997) Leuk Lymphoma , vol.25 , pp. 415
    • Corbi, A.L.1    Lopez-Rodriguez, C.2
  • 30
  • 31
    • 0037314635 scopus 로고    scopus 로고
    • Enzyme-linked immunospet, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma
    • Whiteside TL, Zhao Y, Tsukishiro T, Elder EM, Gooding W, Baar J (2003) Enzyme-linked immunospet, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma. Clin Cancer Res 9:641
    • (2003) Clin Cancer Res , vol.9 , pp. 641
    • Whiteside, T.L.1    Zhao, Y.2    Tsukishiro, T.3    Elder, E.M.4    Gooding, W.5    Baar, J.6
  • 32
    • 0036644333 scopus 로고    scopus 로고
    • Anti-melanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp 100 peptide G209-2M is correlated to TCR avidity
    • Yang S, Linette GP, Longerich S, Haluska FG (2002) Anti-melanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp 100 peptide G209-2M is correlated to TCR avidity. J Immunol 169:531
    • (2002) J Immunol , vol.169 , pp. 531
    • Yang, S.1    Linette, G.P.2    Longerich, S.3    Haluska, F.G.4
  • 35
    • 0037217371 scopus 로고    scopus 로고
    • CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens
    • Javia LR, Rosenberg SA (2003) CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens. J Immunother 26:85
    • (2003) J Immunother , vol.26 , pp. 85
    • Javia, L.R.1    Rosenberg, S.A.2
  • 37
    • 0032960197 scopus 로고    scopus 로고
    • Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation
    • Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T, Grabbe S (1999) Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation. J Immunol 162:168
    • (1999) J Immunol , vol.162 , pp. 168
    • Labeur, M.S.1    Roters, B.2    Pers, B.3    Mehling, A.4    Luger, T.A.5    Schwarz, T.6    Grabbe, S.7
  • 39
    • 0033934838 scopus 로고    scopus 로고
    • Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells
    • Jonuleit H, Giesecke A, Kandemir A, Paragnik L, Knop J, Enk AH (2000) Induction of tumor peptide-specific cytotoxic T cells under serum-free conditions by mature human dendritic cells. Arch Dermatol 292:325
    • (2000) Arch Dermatol , vol.292 , pp. 325
    • Jonuleit, H.1    Giesecke, A.2    Kandemir, A.3    Paragnik, L.4    Knop, J.5    Enk, A.H.6
  • 42
    • 0036378101 scopus 로고    scopus 로고
    • Immature, but not inactive: The tolerogenic function of immature dendritic cells
    • Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H (2002) Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 80:477
    • (2002) Immunol Cell Biol , vol.80 , pp. 477
    • Mahnke, K.1    Schmitt, E.2    Bonifaz, L.3    Enk, A.H.4    Jonuleit, H.5
  • 43
    • 0035862333 scopus 로고    scopus 로고
    • Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
    • Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233
    • (2001) J Exp Med , vol.193 , pp. 233
    • Dhodapkar, M.V.1    Steinman, R.M.2    Krasovsky, J.3    Munz, C.4    Bhardwaj, N.5
  • 44
    • 0034613767 scopus 로고    scopus 로고
    • Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
    • Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192:1213
    • (2000) J Exp Med , vol.192 , pp. 1213
    • Jonuleit, H.1    Schmitt, E.2    Schuler, G.3    Knop, J.4    Enk, A.H.5
  • 45
    • 0035862336 scopus 로고    scopus 로고
    • Differentiation of T regulatory cells by immature dendritic cells
    • Roncarolo M-G, Levings MK, Traversari C (2001) Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 193:F5
    • (2001) J Exp Med , vol.193
    • Roncarolo, M.-G.1    Levings, M.K.2    Traversari, C.3
  • 47
    • 0035866803 scopus 로고    scopus 로고
    • Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein
    • Shimizu K, Thomas EK, Giedlin M, Mule JJ (2001) Enhancement of tumor lysate-and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res 61:2618
    • (2001) Cancer Res , vol.61 , pp. 2618
    • Shimizu, K.1    Thomas, E.K.2    Giedlin, M.3    Mule, J.J.4
  • 48
    • 0037435887 scopus 로고    scopus 로고
    • Dendritic cell KLH loading requirements for efficient CD4(+) T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines
    • Millard AL, Ittelet D, Schooneman F, Bernard J (2003) Dendritic cell KLH loading requirements for efficient CD4(+) T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines. Vaccine 2:869
    • (2003) Vaccine , vol.2 , pp. 869
    • Millard, A.L.1    Ittelet, D.2    Schooneman, F.3    Bernard, J.4
  • 49
    • 0033514937 scopus 로고    scopus 로고
    • Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
    • Shimizu K, Fields RC, Giedlin M, Mule JJ (1999) Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc Natl Acad Sci U S A 96:2268
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 2268
    • Shimizu, K.1    Fields, R.C.2    Giedlin, M.3    Mule, J.J.4
  • 51
    • 0037154222 scopus 로고    scopus 로고
    • Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery
    • Asavaroengchai W, Kotera Y, Mule JJ (2002) Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery. Proc Natl Acad Sci U S A 99:931
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 931
    • Asavaroengchai, W.1    Kotera, Y.2    Mule, J.J.3
  • 53
    • 0035523826 scopus 로고    scopus 로고
    • How melanoma cells evade TRAIL-mduced apoptosis
    • Hersey P, Zhang XD (2001) How melanoma cells evade TRAIL-mduced apoptosis. Nat Rev 1:142
    • (2001) Nat Rev , vol.1 , pp. 142
    • Hersey, P.1    Zhang, X.D.2
  • 54
    • 0038284110 scopus 로고    scopus 로고
    • Overcoming resistance of cancer cells to apoptosis
    • Hersey P, Zhang XD (2003) Overcoming resistance of cancer cells to apoptosis. J Cell Physiol 169:9
    • (2003) J Cell Physiol , vol.169 , pp. 9
    • Hersey, P.1    Zhang, X.D.2
  • 56
    • 0003344106 scopus 로고    scopus 로고
    • Effective melanoma antigen vaccination without dendritic cells (DC): A phase I study of immunization with Mage3 or Melan-A peptide-pulsed autologous PBMC plus RhIL-12
    • Gajewsky TF, Fallarino F, Vogelzang N, Posner MC, Ashikari A, Sherman ML (1999) Effective melanoma antigen vaccination without dendritic cells (DC): A phase I study of immunization with Mage3 or Melan-A peptide-pulsed autologous PBMC plus RhIL-12. Proc ASCO 18:539a
    • (1999) Proc ASCO , vol.18
    • Gajewsky, T.F.1    Fallarino, F.2    Vogelzang, N.3    Posner, M.C.4    Ashikari, A.5    Sherman, M.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.